Vaccine News and Research

Latest Vaccine News and Research

Mass vaccination of poultry needed to prevent bird flu pandemic

At the start of a three-day UN conference in Kuala Lumpur on the bird flu virus, health and animal experts have called for mass vaccination of poultry to prevent bird flu from becoming a human pandemic

4 Jul 2005

Research sheds light on why cervical precancers disappear in some women and not in others

New research sheds light on why cervical precancers disappear in some women and not in others. Scientists say the reason many of these lesions persist is an unlikely mix of human papilloma virus (HPV) strain and a woman’s individual immune system.

4 Jul 2005

University of Michigan receives $10m grant for Alzheimer's research

Alzheimer’s disease research at the University of Michigan is getting a $10 million boost: a major grant that will fund a broad array of efforts aimed at finding and fighting the causes of the disease and other memory conditions.

1 Jul 2005

RxKinetix receives grant to develop thermostable vaccines with improved stability at non-refrigerated temperatures

RxKinetix Inc., a specialty pharmaceutical company has received a grant offer from the prestigious Grand Challenges in Global Health initiative. The grant will be used to develop thermostable vaccines with improved stability at non-refrigerated temperatures for use in the world's poorest countries.

30 Jun 2005

Report highlights importance of research into diseases in developing countries

Better drugs and vaccines are needed to fight HIV/AIDS, tuberculosis (TB), malaria and other tropical diseases. Pharmaceutical research has typically focussed on developing drugs, vaccines and other interventions for diseases prevalent in developed countries, where people can afford to buy treatments; it has tended to overlook those disorders that predominantly affect developing countries.

30 Jun 2005

Another death takes Vietnam's bird flu toll to 39

The death of a 73-year-old Vietnamese from bird flu, has taken the country's death toll from the epidemic to 39.

30 Jun 2005

New drug candidate against HIV-infection

As a part of a research collaboration, scientists at the Sahlgrenska Academy at Gotenborg University, Sweden, have developed a new drug candidate against HIV-infection. The new substance, named alphaHGA, will be tested on patients this year.

30 Jun 2005

Routine immunization virtually eliminates major killer of young children in the Gambia

The Lancet has today published online new research from a team led by the UK Medical Research Council's Richard Adegbola showing that routinely vaccinating infants against H. influenzae type b (Hib) - a bacterium that causes deadly diseases including pneumonia and meningitis - has virtually eliminated Hib meningitis in The Gambia.

29 Jun 2005

MRC study finds vaccine eliminates HIB disease in the Gambia

A Medical Research Council (MRC) study results, announced online today in The Lancet, illustrate that a routine immunisation programme in The Gambia has been successful at eliminating the incidence of Haemophilus influenzae type b (Hib) disease.

28 Jun 2005

Routine immunisation against meningitis and pneumonia should be introduced for children in developing countries

Routine immunisation against a bacterial microorganism that can cause meningitis and pneumonia should be introduced for children in developing countries, suggests a report published in this week’s issue of The Lancet.

28 Jun 2005

Grand Challenges in Global Health awards $450m to top scientists

Grants totalling U.S $450m were awarded yesterday to some of the world's most inventive scientists to enable them to turn their novel ideas into practical solutions to the 14 greatest problems plaguing human health today.

28 Jun 2005

Vaccine against Lassa fever works in monkeys

Scientists say that a genetically engineered virus may possibly offer the first effective vaccine against Lassa fever.

28 Jun 2005

New candidate for a vaccine against Lassa fever

Among the family of viral hemorrhagic fevers (which includes those caused by the Ebola, Marburg, and Hanta viruses), Lassa fever is the biggest public health problem.

28 Jun 2005

Gleevec or similar drugs might be useful in preventing adverse side effects of smallpox vaccine

Mice given a relatively new cancer drug can survive an otherwise lethal dose of vaccinia virus, a relative of smallpox virus, report scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID).

27 Jun 2005

$5.1 billion could save 6 million children

Six million children could be saved if $5.1 billion in new resources for preventive and therapeutic interventions were provided each year, according to researchers from the Johns Hopkins Bloomberg School of Public Health and other institutions.

27 Jun 2005

OHSU scientists say low FOXP3 means fewer disease-fighting cells, but new drug may help multiple sclerosis

Oregon Health & Science University researchers have measured genetic changes reflecting a drop in the body's ability to suppress inflammatory cells that attack nerve fibers and promote progression of multiple sclerosis.

27 Jun 2005

Half a million in U.S. could die in flu pandemic

A report from the Trust for America's Health, says the United States only has 965,256 staffed hospital beds, and in the event of a pandemic, half a million Americans could die and more than 2 million could end up in the hospital with serious complications.

27 Jun 2005

3 health workers arrested after hepatitis vaccine kills a schoolchild and makes 120 others ill

After a hepatitis vaccine was administered in their schools in central China, one child died and another 120 have become ill.

27 Jun 2005

Expert says the world is not ready for the next pandemic

Michael T. Osterholm is Director of the Center for Infectious Disease Research and Policy, Associate Director of the Department of Homeland Security's National Center for Food Protection and Defense, and Professor at the University of Minnesota's School of Public Health.

21 Jun 2005

New Zealand Ministry of Health warns Influenza B can be serious health risk to children and young people

A currently-circulating strain of influenza has not been common in New Zealand since 1987 and means children and young people can be at particular risk of serious illness, the Ministry of Health says.

21 Jun 2005

Vaccine News and Research

Latest Vaccine News and Research

Mass vaccination of poultry needed to prevent bird flu pandemic

Research sheds light on why cervical precancers disappear in some women and not in others

University of Michigan receives $10m grant for Alzheimer's research

RxKinetix receives grant to develop thermostable vaccines with improved stability at non-refrigerated temperatures

Report highlights importance of research into diseases in developing countries

Another death takes Vietnam's bird flu toll to 39

New drug candidate against HIV-infection

Routine immunization virtually eliminates major killer of young children in the Gambia

MRC study finds vaccine eliminates HIB disease in the Gambia

Routine immunisation against meningitis and pneumonia should be introduced for children in developing countries

Grand Challenges in Global Health awards $450m to top scientists

Vaccine against Lassa fever works in monkeys

New candidate for a vaccine against Lassa fever

Gleevec or similar drugs might be useful in preventing adverse side effects of smallpox vaccine

$5.1 billion could save 6 million children

OHSU scientists say low FOXP3 means fewer disease-fighting cells, but new drug may help multiple sclerosis

Half a million in U.S. could die in flu pandemic

3 health workers arrested after hepatitis vaccine kills a schoolchild and makes 120 others ill

Expert says the world is not ready for the next pandemic

New Zealand Ministry of Health warns Influenza B can be serious health risk to children and young people

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in